Regulated Pharmaceutical Packaging and Labeling

The contract involves the final packaging of Dutasteride capsules into bottles containing either 30 or 90 capsules. The packaging process must include compliant labeling consistent with regulatory standards, featuring safety caps along with barcodes, lot numbers, and expiry dates to ensure product traceability and safety. This subcontract is issued by Nac Pharmaceuticals under the Department of Veterans Affairs and falls under the NAICS code 325413, which corresponds to pharmaceutical preparation manufacturing. The solicitation was posted on June 16, 2026, with a response deadline set for July 7, 2026. While specific location details for the place of performance and point of contact are not provided, the contract emphasizes strict adherence to labeling and packaging requirements for regulated pharmaceutical products. The work aims to support the production and distribution of Dutasteride in a manner compliant with industry and regulatory standards.